Then, these fusion proteins can disrupt normal RARα signaling, increase the recruitment of co-blockers, and suppress the transcription of target genes, ultimately preventing differentiation and leading to the development of APL [206,207]. Here, RARA is linked to acute promyelocytic leukemia.